Biocon Biologics and Mylan announce launch of Semglee (insulin glargine injection) in the U.S. to expand access for patients living with diabetes ... Aug 31
TB Alliance announces European commission authorisation of new treatment for highly drug-resistant tuberculosis ... Aug 04
-Advertisements-